Indefinite Delivery Contract SPE2DU25D5141

Award Date 8/1/25
Last Date to Order 12/31/36
Ultimate Awardee
Not listed
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
The Indefinite Delivery Contract (IDC) SPE2DR25D1004 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, aims to establish a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, U.S. Coast Guard, and U.S. Naval Fleet. The...
This Indefinite Delivery Contract (IDC) award, valued at $999,999,999, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The IDC encompasses a broad spectrum of critical medical commodities including...
The Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to AmerisourceBergen Drug Corp, valued at $999,999,999, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a 30-month base period and three 30-month option periods, for a total estimated value of $30.3 billion. The IDC serves as the Pharmaceutical Prime Vendor Global...
The Indefinite Delivery Contract (IDC) SPE2DX25D5000 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain, a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $999,999,999 and runs through March 2035. The purpose of this IDC is to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support,...
The Indefinite Delivery Contract (IDC) SPE2DR25D6035 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, is a single-award IDC with a period of performance through December 31, 2036. The purpose of this IDC is to establish a Pharmaceutical Prime Vendor Global Program to provide worldwide pharmaceutical support, including...
The Indefinite Delivery Contract (IDC) SPE2DR25D1110 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, is an unrestricted, fully competitive acquisition that aims to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to provide worldwide pharmaceutical support to various DoD customers, including...
The Indefinite Delivery Contract (IDC) SPE2DR25D7910 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, has a period of performance through December 2026 and is intended to provide worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, the U.S. Coast Guard, and...
The Indefinite Delivery Contract (IDC) SPE2DR25D1102 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,999,999,999, covers the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This includes specialty medications, brand-name and generic drugs,...
The Indefinite Delivery Contract (IDC) SPE2DR25D3016 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $999,999,999 contract covers a wide range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic areas. The contract serves to provide...
This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $999,999,999, provides worldwide pharmaceutical support to various Department of Defense (DoD) customers, including the Defense Health Agency, DoD entities, the U.S. Coast Guard, and the U.S. Naval Fleet, through the Pharmaceutical Prime Vendor...

The Indefinite Delivery Contract (IDC) SPE2DU25D5141 was awarded by the Defense Logistics Agency (DLA) Troop Support Medical Supply Chain to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, to provide worldwide pharmaceutical support to various DoD customers. The $999,999,999 contract has a 30-month base period and three 30-month option periods, totaling an estimated value of $30.3 billion.

This IDC aims to establish Pharmaceutical Prime Vendor Global Program Generation V contracts to furnish pharmaceutical products, including brand-name and generic drugs, specialty medications, vaccines, syringes, vials, and other medical supplies across multiple therapeutic areas. The contract will support normal day-to-day operations, planned and unplanned contingency, Prime Vendor Readiness, and War Readiness Materiel requirements for both CONUS and OCONUS locations, serving the Defense Health Agency, DoD, U.S. Coast Guard, and U.S. Naval Fleet, including the hospital ships USNS Mercy and USNS Comfort. This unrestricted, fully competitive acquisition will result in multiple regional primary supplier awards and a separate backup supplier award to ensure resilient access to vital pharmaceuticals.

Generated 6/6/25, 9:48 AM